摘要
目的:从政策体系角度出发,分析我国抗菌药物合理用药政策领域政策工具使用情况,为后续相关政策的调整和优化提供参考。方法:采用内容分析和定量分析方法,构建“政策工具—政策过程”二维分析框架,对中央政府颁布的抗菌药物合理用药政策进行分析。结果:纳入分析47份政策文本共生成505条政策文本编码,其中,政策工具维度环境型政策工具运用最多(77.43%,391/505),其次为供给型(18.22%,92/505)和需求型(4.36%,22/505)政策工具;政策发展维度政策规划、政策实施、政策监督、政策评价工具分别占41.19%(208/505)、51.68%(261/505)、3.96%(20/505)、3.17%(16/505)。结论:抗菌药物合理用药政策应适当减少对环境型政策工具的依赖,重视供给型和需求型政策工具的推动和拉动作用,加强在政策发展过程中监督和评价类工具的运用。
Objectives:To analyze the use of policy tools in the field of Chinese policies for rational use of antibacterial drugs,and provide references for the adjustments and optimization of follow-up policies from the perspective of policy system.Methods:Content analysis and quantitative analysis methods were adopted to build a two-dimensional analysis framework of“policy tools and policy process”,in order to analyze the polices promulgated by the Chinese central government for rational use of antibacterial drugs.Results:The 47 policy texts included in the analysis generated 505 policy text codes in total,wherein,environment-based policy tools(77.43%,391/505)were used the most in the dimension of policy tools,followed by supply-based policy tools(18.22%,92/505)and demand-based policy tools(4.36%,22/505).In the dimension of policy development,policy planning tools,policy implementation tools,policy supervision tools,and policy evaluation tools accounted for 41.19%(208/505),51.68%(261/505),3.96%(20/505),and 3.17%(16/505),respectively.Conclusions:The policies for rational use of antibacterial drugs should appropriately reduce its dependence on environment-based policy tools,attach importance to the driving and pulling effects of supply-based and demand-based policy tools,and enhance the utilization of monitoring and evaluation tools in the process of policy development.
作者
荣红国
邢叶一祎
董玥
夏如玉
商洪才
刘建平
费宇彤
RONG Hong-guo;XING Ye-yiyi;DONG Yue;XIA Ru-yu;SHANG Hong-cai;LIU Jian-ping;FEI Yu-tong(Institute for Excellence in Evidence-Based Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China;School of Traditional Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100700,China)
出处
《中国卫生政策研究》
CSCD
北大核心
2021年第8期45-51,共7页
Chinese Journal of Health Policy
基金
国家重点研发计划-中药联合抗生素治疗慢阻肺急性加重期的临床评价和耐药性研究(2018YFE0102300)
北京中医药大学2021年度基本科研业务费项目(2021-JYB-XJSJJ-009)
北京中医药大学2021年度教育科学研究课题(XJY21013)。
关键词
抗生素
抗菌药物
政策工具
政策分析
Antibiotics
Antibacterial drugs
Policy tools
Policy analysis